AASLD strives to review and update its Practice Guidelines every five (5) years, as necessary. Users are cautioned that in the interim, scientific and medical developments may supercede or invalidate, in whole or in part, specific recommendations in any Guideline. A Guideline is considered to be "inactive" if it has not been updated by AASLD in at least five (5) years, and for this reason particular care must be exercised in placing reliance on an inactive Guideline.
AASLD Practice Guidelines are copyright protected. One copy may be accessed for personal research, scientific, scholarly or informational purposes and may be transmitted to a third-party colleague in hard copy or electronically for similar use. Up to three figures, tables and brief excerpts less than 400 words may be used in one’s scientific, scholarly and educational work with appropriate credit. Permission is required to reproduce four or more figures, tables, and sections over 400 words or complete practice guidelines and position papers for systematic redistribution. Re-sale is not allowed. Please contact email@example.com for assistance.
AASLD does not accept corporate support for the development of practice guidelines. However, AASLD gratefully acknowledges the support of Merck and Bayer HealthCare/Onyx Pharmaceuticals in providing independent medical education grants for PDA software applications for AASLD practice guidelines.